WHAT IS MABTAS INJECTION?

Rituximab is a cancer
medication that interferes with the growth and spread of cancer cells in the
body. Rituximab is a monoclonal antibody. Monoclonal antibodies are a
relatively new type of “targeted” cancer therapy.

USES OF MABTAS INJECTION:

Rituximab is used to treat
non-Hodgkin’s lymphoma or chronic lymphocytic leukemia. Rituximab is also used
in combination with another drug called methotrexate to treat symptoms of adult
rheumatoid arthritis. Rituximab is also used in combination with steroid
medicines to treat certain rare disorders that cause inflammation of blood
vessels and other tissues in the body.

POSSIBLE
SIDE EFFECTS:

Rituximab may cause a serious viral infection of the brain that can lead
to disability or death. Call your doctor right away if you have any change in
your mental state, thinking problems or confusion, decreased vision, or
problems with speech or walking. These symptoms may start gradually and get
worse quickly.

You may or may not experience any related side effects
of Mabtas N 500 Mg Injection, such as fever accompanied with
chills, nausea and vomiting, cough,
headache, irritation of the throat and runny nose. If you do experience these
side effects, do not be alarmed, just inform you doctor and he will provide
medicine to control the symptoms.

COMMON SIDE EFFECTS MAY INCLUDE:

There are a few rare
but very serious side effects that can occur when you take Mabtas N 500 Mg
Injection, such as pain in the chest, confusion and problems with breathing.
Get in touch with the doctor immediately in this case and seek treatment.

 

Side Effects of Mabtas are Headache,
Weakness, Edema (swelling), Infection, Hair loss, Itching, Chills, Febrile
neutropenia, Decreased white blood cell count (neutrophils), Infusion reaction.

DRUGS PRECAUTIONS:

Mabtas 500 mg Injection
is a monoclonal antibody that specifically binds to receptors on cancer cells.
Thus it flags the cancer cells for destruction by the body’s immune system.

Seek
immediate medical attention if you develop any severe skin and mouth reactions:
painful sores or ulcers on the skin, lips, or mouth; blisters; rash; or peeling
skin.

Use
rituximab with extreme caution in children and elderly.

Rituximab
may cause a serious viral infection of the brain or progressive multi focal leukoencephalopathy that can lead to disability or death. Consult your doctor
immediately if you experience any change in your mental state, decreased
vision, or problems with speech or walking.

 DRUGS INTERACTIONS:

Take
precautions if you have or had any of the following medical conditions:
hepatitis infection (rituximab could be fatal in such cases), any other
infection such as (herpes, shingles, cytomegalovirus, etc.), systemic lupus
erythematosus, heart problems (such as angina, palpitations or heart failure),
lung disease or breathing problems, taken medicines which affect your immune
system (such as chemotherapy or immune-suppressive medicines) or used certain
arthritis medicines.

You
may be asked to stop taking medicines for high blood pressure 12 hours before
you receive rituximab as it may cause a fall in the blood pressure.

Avoid
activities that may cause bruising or injury as rituximab may reduce the number
of clot-forming cells (platelets) in your blood.

You
may be monitored with regular blood tests before and during the treatment with
rituximab to monitor your condition or check for side effects.

Do
not receive live vaccine (such as measles, mumps, rubella and others) while
using rituximab, and avoid contact with anyone who has recently received a live
vaccine as there are chances that the virus could be passed on to you. 

Use
effective method of contraception while using and after 12 months after your
last treatment with rituximab.